Short Interest in Invesco Pharmaceuticals ETF (NYSEARCA:PJP) Decreases By 39.2%

Invesco Pharmaceuticals ETF (NYSEARCA:PJP) saw a large decrease in short interest in August. As of August 14th, there was short interest totaling 30,384 shares, a decrease of 39.2% from the July 30th total of 49,986 shares. Based on an average daily trading volume, of 35,912 shares, the days-to-cover ratio is currently 0.8 days. Currently, 0.8% of the shares of the stock are sold short.

Invesco Pharmaceuticals ETF Price Performance

Shares of PJP traded down $1.47 during mid-day trading on Monday, reaching $125.79. The company had a trading volume of 2,892 shares, compared to its average volume of 35,207. The company has a market capitalization of $483.03 million, a P/E ratio of 15.59 and a beta of 0.45. Invesco Pharmaceuticals ETF has a twelve month low of $90.01 and a twelve month high of $131.68. The company’s 50-day moving average is $122.12 and its 200-day moving average is $112.08.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the company. Fifth Third Bancorp bought a new stake in shares of Invesco Pharmaceuticals ETF in the 1st quarter valued at about $36,000. Global Assets Advisory LLC bought a new position in shares of Invesco Pharmaceuticals ETF during the first quarter worth approximately $42,000. IFP Advisors Inc raised its stake in Invesco Pharmaceuticals ETF by 31.3% in the fourth quarter. IFP Advisors Inc now owns 440 shares of the company’s stock valued at $46,000 after purchasing an additional 105 shares in the last quarter. International Assets Investment Management LLC acquired a new stake in shares of Invesco Pharmaceuticals ETF in the 4th quarter valued at $64,000. Finally, Rockefeller Capital Management L.P. increased its position in Invesco Pharmaceuticals ETF by 20.5% during the 4th quarter. Rockefeller Capital Management L.P. now owns 1,230 shares of the company’s stock worth $129,000 after purchasing an additional 209 shares in the last quarter.

About Invesco Pharmaceuticals ETF

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.